Thomas Kirk Purchases 31,605 Shares of Myomo (NYSEAMERICAN:MYO) Stock

Myomo, Inc. (NYSEAMERICAN:MYO) Director Thomas Kirk acquired 31,605 shares of the company’s stock in a transaction that occurred on Friday, May 15th. The stock was purchased at an average cost of $0.91 per share, with a total value of $28,760.55. Following the completion of the purchase, the director directly owned 585,462 shares in the company, valued at $532,770.42. This represents a 5.71% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Myomo Stock Performance

Myomo stock opened at $0.88 on Wednesday. The company has a debt-to-equity ratio of 1.21, a quick ratio of 2.36 and a current ratio of 2.73. The stock has a fifty day moving average of $0.77 and a two-hundred day moving average of $0.84. The company has a market capitalization of $33.93 million, a price-to-earnings ratio of -2.44 and a beta of 1.39. Myomo, Inc. has a fifty-two week low of $0.61 and a fifty-two week high of $3.45.

Wall Street Analyst Weigh In

Separately, Craig Hallum restated a “buy” rating on shares of Myomo in a research note on Tuesday, March 10th. Four investment analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock has an average rating of “Buy” and a consensus target price of $7.67.

Hedge Funds Weigh In On Myomo

Several institutional investors have recently made changes to their positions in the stock. Bank of America Corp DE boosted its position in shares of Myomo by 93.6% during the third quarter. Bank of America Corp DE now owns 30,412 shares of the company’s stock worth $27,000 after buying an additional 14,705 shares during the period. Wells Fargo & Company MN boosted its position in shares of Myomo by 103.1% during the fourth quarter. Wells Fargo & Company MN now owns 38,707 shares of the company’s stock worth $35,000 after buying an additional 19,646 shares during the period. Invesco Ltd. acquired a new position in shares of Myomo during the second quarter worth approximately $37,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in shares of Myomo during the second quarter worth approximately $38,000. Finally, Jane Street Group LLC acquired a new position in shares of Myomo during the fourth quarter worth approximately $64,000. 44.99% of the stock is owned by institutional investors.

Myomo Company Profile

Myomo, Inc (NYSE American: MYO) is a medical robotics company specializing in developing and commercializing powered orthotic devices designed to restore mobility and function for individuals with upper-limb weakness. The company’s flagship product, the MyoPro®, is an FDA-cleared, wearable robotic orthosis that leverages proprietary sensors and actuators to detect and amplify users’ own muscle signals, enabling patients with conditions such as stroke, spinal cord injury, muscular dystrophy and other neuromuscular disorders to perform daily activities with greater independence.

Myomo markets the MyoPro through a network of licensed orthotic and prosthetic professionals, clinics and hospitals across North America.